Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|June 23, 2010

IRB Company Receives Full AAHRPP Accreditation

IRB Company, Inc. (IRBCo), an independent review board that protects the rights and well-being of research volunteers participating in human research, announces its Full Accreditation status by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Accreditation by AAHRPP offers assurances to research participants, researchers, sponsors, government regulators and the general public that IRBCo is focused on excellence in its human research protection programs.

"IRBCo has dedicated itself to remaining at the forefront of human research protections, and this voluntary process to earn accreditation required us to examine and review our operations and functions so that we remain a leading provider of central independent review board services," said Anil Sharma, MD, MBA, CIP, the Medical Director and Chief Executive Officer of IRBCo. "Accreditation validates our comprehensive program, which integrates ethical reviews, state-of-the-art technology and staff development."

As an independent, non-profit accrediting body, AAHRPP uses a voluntary, peer-driven educational model to ensure that human research protection programs meet rigorous standards for quality and protection. To earn accreditation, organizations must provide evidence, through policies, procedures and practices, of their commitment to scientifically and ethically sound research and to continuous improvement.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.